ESC Congress 2024: POPular PAUSE TAVI – Continuation or interruption of oral anticoagulation during TAVI?
Luis Ortega-Paz provides his take on the POPular PAUSE TAVI trial presented by Dirk Jan van Ginkel at the ESC Congress 2024 in London. Given that a significant proportion of TAVI patients require OAC due to conditions like atrial fibrillation, the trial aimed to identify the optimal management strategy that minimizes both thromboembolic and bleeding risks.